文献速递遗传性与小管间质肾病肾小球疾病

无 apparent 家族史的多囊肾病遗传与影像分析

Polycystic Kidney Disease without an Apparent Family History.
PubMed 文献 · J Am Soc Nephrol · 2017-05-18

在210例常染色体显性多囊肾病(ADPKD)先证者中,72.2%有阳性家族史,15.3%为新发突变,10.5%家族史不确定,1.9%回顾性发现阳性家族史。新发病例中发现生殖系和体细胞嵌合体,16.3%患者影像呈不典型PKD,部分与嵌合体或未检出突变相关。

要点

  • 约15%的ADPKD患者无阳性家族史,需考虑新发突变、嵌合体或轻症突变。
  • 对家族史阴性的不典型PKD患者,应评估生殖系或体细胞嵌合体可能。
  • 影像学不典型PKD可表现为不对称或局灶性,部分与体细胞嵌合体相关。

核心结论

  • 无 apparent 家族史的PKD可能由新发疾病、父母病历缺失、生殖系或体细胞嵌合体或低效PKD1/PKD2突变所致。

研究设计与样本

  • 多伦多遗传流行病学研究纳入210例ADPKD先证者,进行肾功能检测、腹部影像和PKD1/PKD2突变筛查,并复查父母病历及对父母进行肾影像。

主要发现

  • 209例分析患者中,72.2%(151/209)有阳性家族史,15.3%(32/209)为新发疾病,10.5%(22/209)家族史不确定,1.9%(4/209)回顾性发现阳性家族史。
  • 新发病例中发现2个家系有生殖系嵌合体,1个家系有体细胞嵌合体。
  • 16.3%(34/209)患者影像显示不典型PKD,其中15/34为不对称或局灶性PKD伴阳性家族史及PKD1/PKD2突变,7/34为不对称新发PKD伴证实或疑似体细胞嵌合体,8/34为局灶性PKD无PKD1/PKD2突变。

临床怎么用

  • 对无 apparent 家族史的PKD患者,应详细采集父母病历并考虑对父母进行肾影像以重新评估家族史。
  • 对突变阴性的局灶性PKD患者,需考虑GANAB基因突变和体细胞嵌合体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The absence of a positive family history (PFH) in 10%-25% of patients poses a diagnostic challenge for autosomal dominant polycystic kidney disease (ADPKD). In the Toronto Genetic Epidemiology Study of Polycystic Kidney Disease, 210 affected probands underwent renal function testing, abdominal imaging, and comprehensive PKD1 and PKD2 mutation screening. From this cohort, we reviewed all patients with and without an apparent family history, examined their parental medical records, and performed renal imaging in all available parents of unknown disease status. Subsequent reclassification of 209 analyzed patients revealed 72.2% (151 of 209) with a PFH, 15.3% (32 of 209) with de novo disease, 10.5% (22 of 209) with an indeterminate family history, and 1.9% (four of 209) with PFH in retrospect. Among the patients with de novo cases, we found two families with germline mosaicism and one family with somatic mosaicism. Additionally, analysis of renal imaging revealed that 16.3% (34 of 209) of patients displayed atypical PKD, most of which followed one of three patterns: asymmetric or focal PKD with PFH and an identified PKD1 or PKD2 mutation (15 of 34), asymmetric and de novo PKD with proven or suspected somatic mosaicism (seven of 34), or focal PKD without any identifiable PKD1 or PKD2 mutation (eight of 34). In conclusion, PKD without an apparent family history may be due to de novo disease, missing parental medical records, germline or somatic mosaicism, or mild disease from hypomorphic PKD1 and PKD2 mutations. Furthermore, mutations of a newly identified gene for ADPKD, GANAB, and somatic mosaicism need to be considered in the mutation-negative patients with focal disease.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Iliuta IA, Kalatharan V, Wang K, et al. Polycystic Kidney Disease without an Apparent Family History. J Am Soc Nephrol. 2017. PMID: 28522688. doi:10.1681/ASN.2016090938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。